Since the beneficial effects of some of the bioactive substances present in CTE, and particularly in MetS [27], are reported to be mediated by the activation of the AhR/ARNT pathway, the activation of this pathway was explored as a possible mechanism of action. The gene discussed is ARNT; the disease is metabolic syndrome.